ReNeuron inks stem cell manufacturing pact with Angel Biotech
ReNeuron Group plc has signed two further clinical-grade stem cell manufacturing contracts with Angel Biotechnology Holdings plc (Angel), in support of ReNeuron’s recently approved first-in-man clinical trial with its ReN001 stem cell therapy for stroke patients.
[Read the full article here]Related News:
ReNeuron Successfully Automates Its Stem Cell Manufacturing Process on …
ReNeuron Successfully Automates Its Stem Cell Manufacturing Process on The Automation Partnership's CompacT SelecT …
ReNeuron gives update on progress of stroke stem cell clinical trial